Astellas Pharma Europe BV

Astellas Pharma Europe BV is a company in Leiden, Netherlands that has taken part in 14 EU-funded projects since 2009, receiving €275k in EU funding.

EU funding received€275k
EU projects14
As coordinator0
Running now2
First EU project2009
Latest project2025
CountryNetherlands
EU registration (PIC)994154068
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Astellas Pharma Europe BV's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€275k · 4 projects
  • Horizon 2020€0 · 9 projects
  • Horizon Europe€0 · 1 project

Projects

14 EU-funded projects, newest first. Each links to the official record.

  • BRIDGEPartner

    Breakthrough Regulatory Innovation and Development throuGh sandbox Environments

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

  • BEAMERPartner

    BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe

    Horizon 2020 · 2021–2027 · Project on CORDIS ↗

  • T2EVOLVEPartner

    Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

  • ARDATPartner

    Accelerating Research & Development for Advanced Therapies

    Horizon 2020 · 2020–2026 · Project on CORDIS ↗

  • CAREPartner

    Corona Accelerated R&D in Europe

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

  • MELLODDYPartner

    MachinE Learning Ledger Orchestration for Drug DiscoverY

    Horizon 2020 · 2019–2022 · Project on CORDIS ↗

  • GetReal InitiativePartner

    The GetReal Initiative

    Horizon 2020 · 2018–2021 · Project on CORDIS ↗

  • PIONEERPartner

    Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

  • PREFERPartner

    Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966

    Horizon 2020 · 2016–2022 · Project on CORDIS ↗

  • BEAt-DKDPartner

    Biomarker Enterprise to Attack DKD - Sofia ref.: 115974

    Horizon 2020 · 2016–2023 · Project on CORDIS ↗

  • SPRINTTPartner

    Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies

    FP7 (2007 to 2013) · 2014–2020 · Project on CORDIS ↗

  • TRUSTPartner

    Training Urology Scientists to develop Treatments

    FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

    €239ktheir share
  • FLIPPartner

    Fatty liver: Inhibition of Progression

    FP7 (2007 to 2013) · 2010–2013 · Project on CORDIS ↗

    €36ktheir share
  • EUROPAINPartner

    Understanding chronic pain and improving its treatment

    FP7 (2007 to 2013) · 2009–2015 · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • anatomy and morphology
  • artificial intelligence
  • business models
  • cells technologies
  • coronaviruses
  • databases
  • diabetes
  • drug discovery
  • drug safety
  • gene therapy
  • genomes
  • health care services
  • hepatology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime